Literature DB >> 1552492

Identification of the homozygous recessive genotype for the deficiency of uridine monophosphate synthase in 35-day bovine embryos.

R D Shanks1, R G Popp, G C McCoy, D R Nelson, J L Robinson.   

Abstract

Holstein-Friesian cattle heterozygous for the deficiency of uridine monophosphate (UMP) synthase have half-normal activity of UMP synthase. The homozygous recessive genotype would result in little or no activity, has not been observed among live animals and apparently leads to embryonic mortality at approximately Day 40 of gestation. Activity of UMP synthase averaged 2.74 +/- 0.61 units/mg protein for 19 obligatory normal embryos (from normal x normal matings). Activity for 18 embryos from heterozygote x heterozygote matings yielded three non-overlapping groups as follows: (i) five presumed normals with greater than two-thirds normal activity, (ii) ten apparent heterozygotes with one-third to two-thirds normal activity and (iii) three putative homozygous recessive embryos with less than one-third normal activity. The distribution among these groups was consistent with the 1:2:1 ratio expected for autosomal inheritance. Conception of embryos homozygous recessive for this disorder was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552492     DOI: 10.1530/jrf.0.0940005

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  2 in total

1.  Localization of uridine monophosphate synthase (UMPS) gene to river buffalo chromosomes by FISH.

Authors:  L Iannuzzi; G P Di Meo; A M Ryan; D S Gallagher; L Ferrara; J E Womack
Journal:  Chromosome Res       Date:  1994-05       Impact factor: 5.239

2.  Homozygous haplotype deficiency reveals deleterious mutations compromising reproductive and rearing success in cattle.

Authors:  Hubert Pausch; Hermann Schwarzenbacher; Johann Burgstaller; Krzysztof Flisikowski; Christine Wurmser; Sandra Jansen; Simone Jung; Angelika Schnieke; Thomas Wittek; Ruedi Fries
Journal:  BMC Genomics       Date:  2015-04-18       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.